138 related articles for article (PubMed ID: 38803368)
21. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
[TBL] [Abstract][Full Text] [Related]
22. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
[TBL] [Abstract][Full Text] [Related]
23. The Prognostic Value of Krebs von den Lungen-6 and Surfactant Protein-A Levels in the Patients with Interstitial Lung Disease.
Zheng P; Zheng X; Takehiro H; Cheng ZJ; Wang J; Xue M; Lin Q; Huang Z; Huang H; Liao C; Sun B
J Transl Int Med; 2021 Sep; 9(3):212-222. PubMed ID: 34900632
[TBL] [Abstract][Full Text] [Related]
24. Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients.
Xue M; Zhang T; Chen H; Zeng Y; Lin R; Zhen Y; Li N; Huang Z; Hu H; Zhou L; Wang H; Zhang XD; Sun B
Int J Biol Sci; 2021; 17(6):1565-1573. PubMed ID: 33907520
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer.
Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
Asian Pac J Cancer Prev; 2017 Jan; 18(1):287-291. PubMed ID: 28240848
[TBL] [Abstract][Full Text] [Related]
26. Circulatory Serum Krebs von Den Lungen-6 and Surfactant Protein-D Concentrations Predict Interstitial Lung Disease Progression and Mortality.
Rai M; Parthasarathi A; Beeraka NM; Kaleem Ullah M; Malamardi S; Padukudru S; Siddaiah JB; Uthaiah CA; Vishwanath P; Chaya SK; Ramaswamy S; Upadhyay S; Ganguly K; Mahesh PA
Cells; 2023 Apr; 12(9):. PubMed ID: 37174681
[TBL] [Abstract][Full Text] [Related]
27. Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis.
Choi MG; Choi SM; Lee JH; Kim JY; Song JW
Respir Res; 2022 Dec; 23(1):334. PubMed ID: 36494685
[TBL] [Abstract][Full Text] [Related]
28. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II.
d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372
[TBL] [Abstract][Full Text] [Related]
29. Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China.
Xue M; Zheng P; Bian X; Huang Z; Huang H; Zeng Y; Hu H; Liu X; Zhou L; Sun B; Wu JL; Zhong N
Biosci Trends; 2020 Sep; 14(4):290-296. PubMed ID: 32565512
[TBL] [Abstract][Full Text] [Related]
30. Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis.
He J; Zhang J; Ren X
Front Immunol; 2022; 13():1041098. PubMed ID: 36532009
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature.
Nakao M; Oguri T; Miyazaki M; Uemura T; Takakuwa O; Kunii E; Ohkubo H; Maeno K; Sato S
Exp Ther Med; 2012 Jul; 4(1):141-145. PubMed ID: 23060938
[TBL] [Abstract][Full Text] [Related]
32. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
Iwata H; Haga N; Sugai T; Fujita Y
J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
[TBL] [Abstract][Full Text] [Related]
33. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.
Peng DH; Luo Y; Huang LJ; Liao FL; Liu YY; Tang P; Hu HN; Chen W
Clin Chim Acta; 2021 Jun; 517():48-53. PubMed ID: 33631198
[TBL] [Abstract][Full Text] [Related]
34. [Malignant pleural mesothelioma with multiple nodules].
Asano M; Gemba K; Fujimoto N; Nishi H; Taguchi K; Kishimoto T
Nihon Kokyuki Gakkai Zasshi; 2011 Dec; 49(12):986-9. PubMed ID: 22352064
[TBL] [Abstract][Full Text] [Related]
35. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19: A Systematic Review, Meta-Analysis, and Trial Sequence Analysis.
Shrestha AB; Pokharel P; Singh H; Shrestha S; Fioni
Clin Med Insights Circ Respir Pulm Med; 2023; 17():11795484231152304. PubMed ID: 36710717
[TBL] [Abstract][Full Text] [Related]
36. Krebs von den Lungen-6 (KL-6) as a diagnostic marker for pulmonary fibrosis: A systematic review and meta-analysis.
Wang C; Wang Q; Liu T; Zhu J; Zhang B
Clin Biochem; 2023 Apr; 114():30-38. PubMed ID: 36706799
[TBL] [Abstract][Full Text] [Related]
37. Association of Serum Krebs von den Lungen-6 (KL-6) Levels and Disease Severity in Patients Hospitalized with COVID-19.
Evlice O; Bektaş M; Kar F; Marim F; Kaya İ; Yörükoğlu K; Ak Ö
Infect Dis Clin Microbiol; 2023 Dec; 5(4):292-299. PubMed ID: 38633849
[TBL] [Abstract][Full Text] [Related]
38. Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis.
Pramana Witarto A; Samarta Witarto B; Er Putra AJ; Pramudito SL; Rosyid AN
Iran Biomed J; 2021 Nov; 25(6):381-9. PubMed ID: 34641641
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
[TBL] [Abstract][Full Text] [Related]
40. Rapidly progressive organizing pneumonia associated with COVID-19.
Horii H; Kamada K; Nakakubo S; Yamashita Y; Nakamura J; Nasuhara Y; Konno S
Respir Med Case Rep; 2020; 31():101295. PubMed ID: 33224726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
